Standout Papers

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cance... 1999 2026 2008 2017 8.3k
  1. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2 (2001)
    Dennis J. Slamon, Brian Leyland‐Jones et al. New England Journal of Medicine
  2. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer (2004)
    Soonmyung Paik, Steven Shak et al. New England Journal of Medicine
  3. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease (1999)
    Melody Cobleigh, Charles L. Vogel et al. Journal of Clinical Oncology
  4. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer (2006)
    Soonmyung Paik, Gong Tang et al. Journal of Clinical Oncology
  5. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer (2002)
    Charles L. Vogel, Melody Cobleigh et al. Journal of Clinical Oncology
  6. Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience (2002)
    Andrew D. Seidman, Clifford A. Hudis et al. Journal of Clinical Oncology
  7. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. (1990)
    Steven Shak, Daniel J. Capon et al. Proceedings of the National Academy of Sciences
  8. Prediction of Risk of Distant Recurrence Using the 21-Gene Recurrence Score in Node-Negative and Node-Positive Postmenopausal Patients With Breast Cancer Treated With Anastrozole or Tamoxifen: A TransATAC Study (2010)
    Mitch Dowsett, Jack Cuzick et al. Journal of Clinical Oncology
  9. A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling (2014)
    Eric A. Klein, Matthew R. Cooperberg et al. European Urology

Immediate Impact

5 by Nobel laureates 21 from Science/Nature 210 standout
Sub-graph 1 of 15

Citing Papers

Deciphering breast cancer: from biology to the clinic
2023 Standout
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides
2023 StandoutNature
47 intermediate papers

Works of Steven Shak being referenced

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer
2006 Standout
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
and 16 more

Author Peers

Author Last Decade Papers Cites
Steven Shak 11027 16418 5517 7955 133 27.6k
W. Eiermann 9766 16006 4460 4818 223 23.2k
Edith A. Perez 10865 20395 5671 6462 395 29.5k
Louis Fehrenbacher 7832 24845 10026 8769 156 35.2k
Luca Gianni 8116 19941 5805 7983 305 29.8k
Sandra M. Swain 7045 15005 4681 5006 334 22.7k
Michael F. Press 8487 19794 4674 9503 222 29.9k
Jonas Bergh 11360 15296 4816 10934 510 28.3k
Torsten O. Nielsen 13229 14868 7295 9819 241 28.8k
Ana M. González-Angulo 11118 14849 5020 8771 278 24.6k
Mark D. Pegram 4825 17466 4493 6675 219 23.2k

All Works

Loading papers...

Rankless by CCL
2026